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Transplantation of GABAergic interneurons (INs)
can provide long-term functional benefits in animal
models of epilepsy and other neurological disor-
ders. Whereas GABAergic INs can be differentiated
from embryonic stem cells, alternative sources
of GABAergic INs may be more tractable for dis-
ease modeling and transplantation. We identified
five factors (Foxg1, Sox2, Ascl1, Dlx5, and Lhx6)
that convert mouse fibroblasts into induced
GABAergic INs (iGABA-INs) possessing molecular
signatures of telencephalic INs. Factor overexpres-
sion activates transcriptional networks required
for GABAergic fate specification. iGABA-INs
display progressively maturing firing patterns
comparable to cortical INs, form functional synap-
ses, and release GABA. Importantly, iGABA-INs
survive and mature upon being grafted into mouse
hippocampus. Optogenetic stimulation demon-
strated functional integration of grafted iGABA-
INs into host circuitry, triggering inhibition of host
granule neuron activity. These five factors also
converted human cells into functional GABAergic
INs. These properties suggest that iGABA-
INs have potential for disease modeling and cell-
based therapeutic approaches to neurological
disorders.CellINTRODUCTION
The imbalance between the excitatory and inhibitory tone in ce-
rebral neuronal networks causes epilepsy and other neurological
disorders. GABAergic (g-aminobutyric acid-secreting) interneu-
rons (INs) account for the inhibitory tone in the cerebral cortex
and hippocampus, which are considered the most epileptogenic
regions of the brain. Drug treatments result ineffective for many
patients and surgical resection of the epileptic focus often
causes severe neurological defects. For these reasons, new
treatments complementary to the pharmacological therapy
need to be developed.
GABAergic INs arise from precursors located in the medial
and caudal ganglionic eminence (MGE and CGE, respectively)
from where they migrate out to integrate into the circuitry of
the developing striatum, cortex, and hippocampus (Marı´n
and Rubenstein, 2001; Anderson et al., 2001). Transplanted
MGE cells mature into GABAergic INs, integrate into the host
neural circuits, increase the level of GABA-mediated synaptic
inhibition in the surrounding tissue (Alvarez-Dolado et al.,
2006) and reduce seizures in epileptic mice (Baraban et al.,
2009; Calcagnotto et al., 2010; Hunt et al., 2013). Given
these properties, transplantation of IN precursors might
offer a cell-based therapeutic prospective for some forms
of epilepsies. Of note, IN grafts might be therapeutic for other
neurological disorders including mood disorders, chronic pain,
Parkinson and Alzheimer diseases by promoting neuronal
circuit plasticity (Southwell et al., 2010; Martı´nez-Cerden˜o
et al., 2010; Bra´z et al., 2012; Gilani et al., 2014; Tong et al.,
2014).Stem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Inc. 719
Figure 1. A Combination of Five TFs Con-
verts Murine Fibroblasts into iGABA-INs
(A) GFP andGABA (inset) detection inGAD67-GFP
adult brain. Cx, cortex; Hip, hippocampus.
(B) Scheme of the reprogramming strategy with a
dual regulation in the expression of Foxg1-Sox2
and Ascl1-Dlx5-Lhx6.
(C) Staining for TUBB3 and GFP at 21 DIV and
relative quantifications.
(D) Quantifications of the percentage of TUBB3+
and GAD67-GFP+ cells over plated MEFs.
(E–L) Staining of iGABA-INs for GAD (E), GABA (F),
ARX (G), NKX2.1 (H). Stainings for PV (I and J) and
Kv3.1b (K and L) in iGABA-INs and native neurons
(white arrow, inset in K).
(M) Quantifications of the percentage of GAD67-
GFP+ cells expressing each GABAergic marker
over the total of GAD67-GFP+ cells.
Data are presented as means ± SD. In (C)–(I), (K),
and (L), Hoechst was used to stain nuclei. See also
Figures S1 and S2.To move this approach into clinical applications, a renewable,
safe, and standardized source of GABAergic INs needs to be
developed. Mouse and human embryonic stem cells (ESCs)
and induced pluripotent stem cells (iPSCs) have been differenti-
ated into GABAergic INs (Maroof et al., 2010, 2013; Danjo et al.,
2011; Nicholas et al., 2013; Tyson et al., 2015). A faster and
potentially safer alternative is represented by directly reprog-
rammed neurons, generated by the conversion of fibroblasts
through the supraphysiological expression of lineage-specific
transcription factors (TFs) (Vierbuchen et al., 2010). However,
despite different iN subtypes have been generated (Caiazzo
et al., 2011; Son et al., 2011, Liu et al., 2013; Victor et al.,
2014), whether GABAergic INs can be obtained with this
approach has not been addressed yet.
Herein, we identified a combination of five TFs (Foxg1,
Sox2, Ascl1, Dlx5, and Lhx6), reducible to four (being Dlx5
dispensable), which are able to convert mouse fibroblasts in
GABAergic INs-like cells (iGABA-INs) with high efficiency and
in short time. We discovered that cooperation of Ascl1, Foxg1,
and Sox2, but not Ascl1 alone, is necessary and sufficient to
maximize GABAergic neuronal fate induction both in fibroblast
reprogramming aswell as during embryonic development in vivo.720 Cell Stem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Inc.iGABA-INs activate a large array of
telencephalic GABAergic IN specific
markers. They also produce and release
GABA and functionally integrate into
neuronal networks both in vitro and
in vivo. The same five TFs are able to
convert human cells into GABAergic
neurons.
RESULTS
Screening of TFs to Convert
GAD67-GFP Fibroblasts into
Telencephalic GABAergic INs
Taking advantage of the knowledge of
the transcriptional hierarchies controllingGABAergic IN differentiation in the forebrain, we selected and
cloned 22 TFs into doxycycline (dox)-inducible lentiviral vectors
for a combinatorial screening to convert mouse embryonic fibro-
blasts (MEFs) into GABAergic INs (Table S1). To follow in real
time the fate switching, we derived MEFs from GAD67-GFP
mouse embryos (Tamamaki et al., 2003) (Figure 1A). Given the
dominant role of Ascl1 in determining the GABAergic identity
(Fode et al., 2000), we conceived an ‘‘adding one TF’’ strategy
where Ascl1was added to any other TF in a two-factor combina-
tion. Ascl1 (A) can trigger by itself conversion of MEFs into
b-III-tubulin+ (TUBB3) neuronal cells but few cells activated
GFP expression (Figure S1I). Conversely, when Ascl1 was com-
bined with either Foxg1 (F) or Sox2 (S), a discrete subset of
reprogrammed cells were double positive for GFP and TUBB3
and the percentage of GFP+TUBB3+ cells substantially
increased when the three TFs were combined together (Figures
S1A, S1E, and S1I). Neuronal cells showed still an immature
morphology, thus we proceeded adding any other factor to the
AFS combination. Lhx6 (L) showed an additive effect, increasing
the number of GFP+TUBB3+ cells (Figures S1C, S1G, and S1I).
Among the Dlx factor family members, Dlx5 (D5) produced the
best result in switching on the GFP reporter in TUBB3+ cells
and therefore it was selected (Figures S1B, S1F, and S1I). More-
over, in both combinations an increased tendency of cells to ac-
quire bipolar morphology was observed. The highest efficiency
was obtained combining Lhx6 and Dlx5 with AFS (Figures S1D,
S1H, and S1I). No further gain was observed by adding every
other factor to this set of genes (data not shown). The same
cocktail was proficient in reprogramming adult mouse fibro-
blasts to GAD67-GFP+ neurons with good efficiency (GFP+/
TUBB3+ cells on the total of plated fibroblasts = 9.4 ± 2.1%,
n = 3, data not shown).
Given the poor morphology of AFSD5L reprogrammed cells,
we reasoned that the prolonged expression of Sox2 and Foxg1
could interfere with neuronal maturation, because during devel-
opment they are mainly expressed in progenitors. Thus, we
devised a dual-system for inducing the five TFs over different
time windows: Sox2 and Foxg1 were kept under TetO promoter
and induced for 12–14 days in vitro (DIV) whereas Ascl1, Dlx5,
and Lhx6 were put under a constitutive promoter (hEF1-alpha)
(Figures 1B and S2A). At 21 DIV, we observed that the dual
regulation protocol did not change substantially the efficiency
in GFP activation but it affected the morphology of reprog-
rammed neurons (Figures S2B–S2C0 0) with a 3-fold increase in
the percentage of bipolar neurons (Figures S2D and S2E).
During the first days of reprogramming, we observed the
formation of small clones of GAD67-GFP+ cells. To assess if
AFSD5L cocktail was inducing cell proliferation, we stained cells
for KI67: at 5 DIV 30% of GAD67-GFP+ cells were positive for
KI67 whereas at 21 DIV no KI67+GFP+ cell was detected (Fig-
ures S2F–S2H). These data suggest that AFSD5L-induced cells
may undergo few rounds of cell division and ultimately exit cell
cycle. Administration of a 12-hr EdU pulse at 1 to 2 DIV followed
by immunofluorescence at 5 DIV, revealed that only a small
fraction of GAD67-GFP+ were also EdU+, indicating that
proliferation is not a necessary condition for reprogramming
(Figures S2I–S2K). Moreover, no marker of stem cell pluripo-
tency was detected, ensuring that AFSD5L-induced conver-
sion of MEFs into GAD67-GFP+ neuronal cells is direct (Figures
S2L–S2Q).
Then, we closely investigated the identity of the induced
neuronal cells. Most of the GAD67-GFP+ cells were positively
stained for glutamic acid decarboxylases (GAD65/67) and
GABA (Figures 1E, 1F, and 1M). We asked whether the five
TFs were sufficient to provide the induced cells with a regional
specification. GABAergic induced cells were found positive for
ARX, a transcription factor expressed in forebrain INs and regu-
lating their migration and specification (Kitamura et al., 2002; Co-
lasante et al., 2009) (Figures 1G and 1M). In induced neurons the
endogenous genetic loci of all the TFs used for the reprogram-
ming were activated (Figure 2E) together with several markers
of cortical INs such as Dlx1, Dlx2, Sox6, Satb1, and ErbB4. On
the other side, expression levels of ER81 (identifying pallidal pro-
jection neurons), Sp8 (olfactory bulb INs), Darpp32 (striatal pro-
jection neurons), Chat and Lhx8 (cholinergic INs) were compara-
ble to those of cortical INs (Figure 2G). In line with an acquired
rostral character, induced cells did not express Helt, and Pax2,
Ptf1a and Gbx2, molecular markers of GABAergic populations
of midbrain, cerebellum, and hindbrain, respectively (Figure 2H).
Nkx2.2, a marker of thalamic regionalization was only transiently
induced in the first phase of differentiation and quickly downre-Cellgulated already 1 week after dox withdrawal. Only rarely
reprogrammed cells were positive for NKX2.1 marker (Figures
1H and 1M). Given these results, we named these cells induced
GABAergic INs (iGABA-INs).
At 21 DIV, most iGABA-INs were parvalbumin+ (PV+) whereas
other IN markers such as somatostatin (SST), reelin (Reel), calre-
tinin (Calr), calbindin (Calb), and vaso-intestinal peptide (VIP)
were poorly represented (Figures 1I, 1J, 1M, and 2G and data
not shown). Interestingly, iGABA-INs were positive for Kv3.1b,
a K+ channel characteristic of PV INs (Du et al., 1996; Erisir
et al., 1999) (Figures 1K–1M).
Reprogrammed Molecular State of iGABA-INs Is
Confirmed by Genome-wide Expression Profiling
To get a global view of the reprogramming state of iGABA-
INs, RNA-sequencing was performed. At 14 DIV, GAD67-
GFP+ iGABA-INs underwent fluorescence-activated cell sorting
(FACS) (Figures S3A and S3B) and processed for RNA extraction
and sequencing. Their transcriptome was compared with those
of GAD67-GFP+ cortical INs (cINs) sorted from E18.5 cortices
(positive control) (Figure S3B) and of the non-induced (NI)
MEFs. The heatmaps of iGABA-INs and cINs show a comparable
pattern, indicating that the five TFs induce a transcriptome shift
from fibroblasts toward cortical GABAergic INs (Figures 2A and
S3C). Of note, many genes with restricted neuronal expression
were upregulated in iGABA-INs, such as Tubb3, Dcx, Syt,
Gprin1, and Gabrb3, together with numerous K+ and Na+ chan-
nels (Kcnq2, Kcnip2, Kcnn3, Scn2b, Kcnk3, Cacna11, and
Scn11a) (Figure 2B). Furthermore, several critical components
of the GABAergic IN transcriptional cascade were expressed in
iGABA-INs including Dlx1, Dlx2, Dlx6, and Arx (Figure 2C).
Gad1 and Gad2, encoding for GABA producing enzymes
(GAD67 and GAD65) and Slc32a1, codifying for the vesicular
GABA transporter v-GAT, showed a robust induction (Figure 2C).
According to our immunofluorescence data, Pv and Kcnc1 were
found upregulated, whereasCalb1,Calb2,Reelin, andCholecys-
tokinin were only minimally increased or silent in iGABA-INs
(Figure 2C). Conversely, several genes expressed in the MEF
preparation Twist1, Col9a2, Col24a1, Ecm1, Tbx2, and Tbx4
were downregulated or silenced in iGABA-INs (Figures 2D and
2F). These findings indicate that the five TFs activate a multitude
of neuronal and synaptic genes and of critical determinants of
forebrain GABAergic INs while leading to a significant loss of
fibroblast molecular hallmarks.
To evaluate the stability of iGABA-IN reprogramming over
time, we put Ascl1 first (AFS+D5L) and then Dlx5 and Lhx6
(AFSD5L) under the control of dox-inducible promoter, together
with Foxg1 and Sox2. Infected cells were sorted and analyzed at
21 DIV, 7 days after dox withdrawal (Figure S3D). After assessing
effective downregulation of inducible viral genes (Figure S3E)
and activation of endogenous AFSD5L genes (Figure 2E), we
analyzed both AFS+D5L and AFSD5L infected cells for the
expression of GABAergic INmarkers finding that they were upre-
gulated to levels comparable to classical iGABA-INs (FS+AD5L)
(Figure S3F). Although analysis at later time-points would be
required, the induction of the endogenous counterparts of the
AFSD5L TFs suggests that the GABAergic IN transcriptional
program could be maintained even when the expression of the
transgenes is silenced.Stem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Inc. 721
Figure 2. iGABA-INs Display Molecular Properties of Forebrain GABAergic INs
(A) Heatmap of genes differentially expressed in RNA-sequencing analysis performed on MEFs (NI), iGABA-INs, and E18.5 GAD67-GFP+ cINs.
(B–D) Heatmaps reporting neuronal specific genes (B), GABAergic IN-specific genes (C), and fibroblast specific genes (D).
(E) Quantitative RT-PCRs for endogenous expression of Ascl1, Foxg1, Sox2, Dlx5, and Lhx6 performed on AFSD5L6, AFS+D5L6, and FS+AD5L6 at 14 and
14+7 DIV.
(F–H) Quantitative RT-PCRs for fibroblast markers (F), for cortical IN lineage markers (G), and other neuronal lineage markers (H) on iGABA-INs at 14 and
14+7 DIV.
Fold changes in gene expression are relative to MEFs for (E)–(G) and relative to cINs for (H). Data are presented as means ± SD. See also Figure S3.
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Sox2 and Foxg1CooperatewithAscl1 inGABAergic Fate
Induction
Our screening revealed that Ascl1 is effective in activating
GAD67-GFP only in combination with either Sox2 or Foxg1,
whose role in regulating the competence of telencephalic pro-
genitors to adopt subpallial fates has been recently proposed
(Manuel et al., 2010; Ferri et al., 2013). Conversely, the role of
ASCL1 as an upstream regulator of Dlx1/2 has been well estab-
lished (Casarosa et al., 1999; Yun et al., 2002) and its ectopic
expression in cortical ventricular zone (VZ) leads to the upregu-
lation of Dlx1/2 (Fode et al., 2000), which in turn activates
GAD65/67 expression (Stu¨hmer et al., 2002). Cortical VZ cells
express Sox2 and Foxg1 at that stage, but their participation
in GABAergic induction has not been ascertained. Moreover,
Ascl1 ectopic expression in MEFs, which expressed neither
Sox2 nor Foxg1, generates glutamatergic but not GABAergic
neurons (Vierbuchen et al., 2010). We hypothesized that also
during embryonic development the cooperation between
Ascl1, Sox2, and Foxg1 is required for GABAergic induction.
To assess this, we first showed that delivering Ascl1 with a con-
trol shRNA by in utero electroporation (IUE) in embryonic day (E)
13.5 developing cortex is able to ectopically activate Dlx2 (at
E15.5) and subsequently Gad1 (at E18.5) (Figures 3B–3F). This
ability was abolished when Ascl1 was delivered in association
with Sox2 or Foxg1 shRNAs (Figures S4A–S4E and 3C–3H).
The effect was quantified by qRT-PCR analysis on FACS-sorted
GFP+ cells isolated from injected cortices (Figures 3J and S4I)
demonstrating that Sox2 as well as Foxg1 silencing impaired
Ascl1-mediated activation of Dlx1, Dlx2, Gad1, and Gad2 genes
(Figures 3I, 3J, and S4J). Finally, to confirm these results at sin-
gle cell level, we overexpressed Ascl1 and mCherry with the
Sox2 shRNA or its control shRNA in the GAD67-GFP cortices.
Quantifications of the electroporated cells expressing the
GAD67-GFP (GFP+mCherry+) confirmed that Sox2 silencing
caused a robust loss of ectopically induced GABAergic neurons
in the cortical tissue (Figures S4F–S4H). Taken together, these
results indicate that the progression in GABAergic neuronal line-
age is ensured by the cooperation between Ascl1, Sox2, and
Foxg1.
Next, we sought to determine the molecular mechanism
through which the TFs can promote the GABAergic neuronal
commitment (Figure 3K). A mechanism by which ASCL1 can
activate Dlx1/2 genes by direct binding to the I12b intergenic
region has already been described (Poitras et al., 2007). To
assess if SOX2 and FOXG1 are also able to bind the same regu-
lative region, we performed chromatin immunoprecipitation
(ChIP) experiments for ASCL1, SOX2, and FOXG1 on chromatin
derived from E14.5 ventral telencephali. Intergenic region of
Dlx1 and Dlx2 genes was significantly enriched in both the
anti-ASCL1 and anti-SOX2 immunoprecipitated samples with
respect to the GFP control but no enrichment for FOXG1 was
reported (Figure 3L). To ascertain if ASCL1 and SOX2 might
be participating in the same molecular complex, we tested
their interaction both in vitro and in vivo. Interestingly, ASCL1
and SOX2 were co-immunoprecipitated in overexpression in
HEK293T cells as well as in physiological conditions using
nuclear protein extracts of E14.5 ventral forebrains (Figure 3M).
In agreement with the ChIP data, FOXG1 was not found in
the same molecular complex (data not shown). Taken togetherCellthese data indicate the existence of an interaction between
ASCL1 and SOX2 at the I12b intergenic enhancer of Dlx1 and
Dlx2.
To determine if this molecular interaction occurs also during
fibroblast reprogramming we performed ChIP for ASCL1,
SOX2, and control GFP on fibroblasts at 10 DIV after infection
with the A, AS, and AFS combinations. A significant enrichment
of both ASCL1 and SOX2 proteins at the I12b enhancer was
found only when also FOXG1 was expressed in the fibroblasts
(Figure 3N). These results indicate that FOXG1 does not bind
per se to I12b, but it permits the ASCL1-SOX2 complex to asso-
ciate with the enhancer region and to activate Dlx genes. To
strengthen this conclusion, we generated a lentiviral vector car-
rying GFP under the control of I12bminimal enhancer and used it
to transduce MEFs in association with different combinations of
Ascl1, Sox2, and Foxg1 (A, F, S, AF, AS, and AFS) (Figure S4K).
AD5 combination was used as a positive control. At 10 DIV, the
percentage of GFP+ cells over the total was determined. Only a
modest increase of GFP+ cells was detected in the combinations
A, F, S, and AF. However, AS, AFS, and AD5 combinations
were able to activate the reporter in approximately 17%, 30%,
and 37% of total cells, respectively (Figure S4L). This set of
results confirm that ASCL1 and SOX2 alone display modest
ability to bind and activate the I12b enhancer but when com-
bined together their trans-activating proficiency increases;
adding FOXG1 to AS combination further increases I12bGFP
expression.
Functional Maturation of the Excitability Properties of
iGABA-INs In Vitro
To assess if iGABA-INs exhibit the functional properties of
forebrain GABAergic INs, we characterized their membrane
properties and excitability in vitro. To promote their functional
maturation, GAD67-GFP+ iGABA-INs were FACS sorted at 12–
14 DIV, plated on primary cultures of rat hippocampal neurons
and analyzed at various time-points (1, 2, 3, and 4 weeks) (Fig-
ure S5A). In co-culture, iGABA-INs were identified by GFP
expression (Figures 4A and S5B, S5E). Until 2 weeks after replat-
ing, iGABA-INs were still immature, as far as resting membrane
potential, membrane capacitance (Cm), input resistance, and
excitability are concerned (Figures 4B–4D). At 4 weeks, they
showed an increase in Cm accompanied by a decrease in mem-
brane resistance (Rm) and by a more hyperpolarized voltage
threshold. These changes in the passive properties correlated
with the progressive maturation of the cell body size and den-
dritic tree (Figures 4A, S5B–S5D, and Table S3). Moreover, the
resting membrane potential became more hyperpolarized and
current injection was able to consistently activate firing activity
(Figures 4B–4D).
At this stage, iGABA-INs were able to fire repetitively at high
frequency, up to 72Hz, and recapitulate the strong action poten-
tial (AP) reliability at high frequency typical of the INs (Figures 4E
and 4F). They also displayed a clear functional maturation of
excitability characterized by a more hyperpolarized voltage
threshold, a progressive decrease in current threshold and AP
width, accompanied by a clear-cut increase in the evoked firing
rate, AP amplitude and rising slope (Figures 4G and 4H; Table
S3). To define the contribution of Na+- and K+-channels during
the maturation in culture, we used voltage-clamp recordingStem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Inc. 723
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(Figure 4I). The complete iGABA-IN channel maturation occurred
at 3 weeks in co-culture with larger Na+- and K+-currents (Fig-
ures 4J and 4K). All together, these results demonstrate that
iGABA-INs undergo a progressive maturation, acquiring high-
frequency firing properties of GABAergic INs after 4 week co-
culture. We showed that endogenous expression of the Dlx
genes is induced in iGABA-INs (Figures 2 and 3) and indeed
the efficiency in reprogramming does not change drastically in
the absence of Dlx5 (Figure S1). Thus, we decided to assess
whether a four-TF combination was able to trigger MEF reprog-
ramming into functional GABAergic cells. Interestingly, we found
that functional properties of GABAergic cells generated without
Dlx5 were comparable to those of iGABA-INs (Figures S5F–
S5I), indicating that Dlx5 in the reprogramming cocktail is
dispensable for obtaining functional neurons.
iGABA-INs Can Functionally Integrate into Synaptic
Circuits
Next, we assessed whether iGABA-INs can integrate into the
synaptic circuits of primary hippocampal neurons. The morpho-
logical development of synaptic contacts was verified by trans-
mission electron microscopy (TEM) using immunogold labeling
for GFP. The ultrastructural analysis revealed that iGABA-INs
exhibit mature pre- and post-synaptic specializations after
3 weeks in co-culture (Figures 5A–5C). Accordingly, post-synap-
tic markers such as GABAA receptor and HOMER1 were
expressed (Figures 5D and 5E). The analysis of spontaneous
inhibitory and excitatory postsynaptic currents (sIPSCs and
sEPSCs) revealed a progressive increase of functional synaptic
contacts formed by feeder neurons with iGABA-INs, reaching
100% of recorded cells at 3 weeks in co-culture even in absence
of Dlx5 (Figures 5F and 5G).
After 3 weeks in co-culture, GABA and its vesicular transporter
VGAT were correctly localized in puncta along iGABA-IN
neurites (Figures 5H–5I0). Moreover, even without co-culture,
iGABA-INs were competent in releasing GABA into the medium
at levels comparable to those secreted by a quantitatively similar
population of primary cINs (Figure 5J).
To demonstrate that iGABA-INs were able to develop func-
tional GABAergic transmission and to inhibit surrounding neu-
rons into the network, we used an optogenetic strategy after in-
fecting the cells with a channelrhodopsin 2 (ChR2)-encoding
lentivirus. Cells were sorted for GAD67-GFP expression and
plated in co-culture (Figure 5K). A control to ensure the absence
of any cross-infection of primary neurons by ChR2 viral particles
residual after FACS was performed with a tdTomato lentivirusFigure 3. Cooperation between Ascl1, Foxg1, and Sox2 Is Required to
(A–D0 0) GFP staining on E15.5 sections of IUE brains at E13.5 with shCtrl+GFP (A),
relative in situ hybridization for Dlx2 (A0–D0) and Gad1 (A0 0–D0 0).
(E–H0 0) The same experiment performed on E18.5 brains.
(I) Scheme of IUE at E13.5 followed by dissection and sorting of GFP+ cells, pro
(J) qRT-PCRs for Dlx1, Dlx2, Gad1, and Gad2 on GFP+ sorted cells (n = 3).
(K and L) ChIP experiment onDlx1/2 cluster intergenic region (K) for ASCL1, SOX2
results are percentage of input and normalized on GFP and an unrelated region.
(M) ASCL1-SOX2 coIP under overexpression conditions in HEK293T cells and e
(N) ChIP for GFP, ASCL1, and SOX2 performed on fibroblasts transduced with S,
GFP and a control unrelated region (n = 3). ns, not significant; *p < 0.05; **p < 0.01;
test. In (A)–(H), Hoechst was used to stain nuclei.
See also Figure S4.
Cell(Figures S5J and S5K). After 3 weeks, ChR2-expressing
iGABA-INs were stimulated by blue light (473 nm) pulses
while feeder cortical neurons were recorded in voltage-clamp
(Figures 5L and 5M). In this configuration, we recorded evoked
inhibitory postsynaptic currents in feeder cortical neurons that
were tightly linked to light activation of iGABA-INs (Figure 5N,
top images). These eIPSCs were characterized by a long
decay time (49.6 ± 4.4 ms, n = 11) typical of GABAA Cl
 currents
and were selectively blocked by bicuculline (Figure 5N). More-
over, when iGABA-INs were stimulated by a paired pulse
protocol of two consecutive light stimuli, eIPSCs showed a
strong paired-pulse depression at short interpulse intervals,
which disappeared at longer interpulse intervals, resembling
inhibitory synaptic transmission in culture (Figure 5N, bottom
images). All together, these data confirm that iGABA-INs are
competent to synaptically connect with host neuronal networks
in vitro and to exert an inhibitory function through direct GABA
release.
iGABA-INs Integrate in Functional Hippocampal Circuits
To test whether the iGABA-INs were able to integrate into a func-
tional network in vivo and form synapses with host neurons, we
stereotactically transplanted reprogrammed cells at 14 DIV in
adult mouse hippocampi (Figure 6A). Six weeks after transplan-
tation, GAD67-GFP+ iGABA-INs could be scored in the hippo-
campus (Figures 6B and S6A–S6C) and positively stained for
GABA (Figures 6E–6E0 0) although, unexpectedly, PV staining
could not be detected (data not shown). Quantification revealed
that 18.0% ± 4.9% of the total transplanted iGABA-INs survived
at that time point. Although not exhibiting an extensive migratory
ability, several cells were found at different distances away from
the injection site migrating toward the dentate gyrus (DG) or CA1
(Figures 6F–6I and S6D). Few cells showing a very mature
morphology were integrated into the granule layer (Figures 6C
and 6D).
To test the electrical activity of these cells, we used patch-
clamp recordings in acute hippocampal slices obtained
from transplanted mice 6 weeks after the injections. Grafted
iGABA-INs displayed repetitive AP firing (10–15 Hz) and size-
able voltage-gated Na+ and K+ currents (Figure 6K). Both spon-
taneous EPSCs and IPSCs were detected in all iGABA-INs
during voltage-clamp recordings (Figures 6L and 6M). These
results suggest that the transplanted cells were electrically
excitable and received both excitatory and inhibitory projec-
tions from local host hippocampal neurons and INs, respec-
tively. Furthermore, optical stimulation of iGABA-INs led to aInduce GABAergic Commitment during Embryonic Development
Ascl1+shCtrl+GFP (B), Ascl1+shSox2+GFP (C), Ascl1+shFoxg1+GFP (D), and
cessed for RNA extraction.
, and FOXG1 (L) performed on E14.5 ventral forebrain chromatin (n = 3). Shown
ndogenous ASCL1-SOX2 coIP in E14.5 ventral forebrain.
AS, and AFS. Results are shown as the percentage of input and normalized to
***p < 0.001, one-way ANOVA followed by theBonferroni’s multiple comparison
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Figure 4. iGABA-INs Display a Progressive Maturation of Their Firing Properties over Time in Culture
(A) Representative pictures showing a progressive increase of iGABA-IN neurite arborization at 1–4 weeks.
(B) Cm/Rm correlation (left) and membrane resting potential (right) at 1–4 weeks.
(C and D) Representative traces of iGABA-IN firing activity maturation over time in vitro and relative maximum firing rate and current threshold density at
1–4 weeks: 1 (n = 14), 2 (n = 27), 3 (n = 14), and 4 weeks (n = 13). One-way ANOVA followed by Bonferroni’s multiple comparison test versus 4 weeks.
(E) Representative trace of iGABA-INs high-frequency firing (72 Hz) at 4 weeks.
(F) AP reliability of iGABA-INs (red, n = 11), excitatory (white, n = 5), and inhibitory neurons (GAD67-GFP+; black, n = 6) at 4 weeks. Two-way ANOVA followed by
Bonferroni’s multiple comparison test versus inhibitory neurons.
(G) Representative traces of the first AP shape elicited at the current threshold at 1, 3, and 4 weeks.
(H) Afterhyperpolarization (AHP), AP amplitude, width at half-maximal amplitude and voltage threshold were calculated from the first AP elicited at the current
threshold and are shown asmeans ± SEMat 1 (n = 7), 2 (n = 19), 3 (n = 10) and 4 (n = 13) weeks. One-way ANOVA followed by the Bonferroni’smultiple comparison
test versus 4 weeks.
(I) Representative voltage-clamp recordings showing inward Na+-currents followed by outward K+-currents at 3 weeks in vitro.
(J and K) Voltage-current relationships for Na+ (J) and K+ (K) currents at 3 weeks. Points in the plots are means ± SEM (n = 10). Insets show the peak amplitude of
Na+- and K+-currents at 1 (n = 10), 2 (n = 10) and 3 (n = 10) weeks. One-way ANOVA followed by the Bonferroni’s multiple comparison test. *p < 0.05; **p < 0.01;
***p < 0.001.
See also Figure S5.
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net 3-fold inhibitory effect on the frequency of spontaneous
EPSCs recorded in granule neurons (Figures 6N and 6O)
and induced bicuculline-sensitive IPSPs (Figure 6O). Light-
evoked unitary IPSCs recorded in voltage-clamp reverted
at 60 mV (Figure 6P), which is close to the calculated
reversal potential for Cl ions (59 mV) in our experimental
conditions.
These results demonstrate that the transplanted iGABA-INs
functionally integrated in the host neural network and established
functional interneuron-like inhibitory GABAergic synapses.
iGABA Neurons Can Be Generated from Human iPSCs
and Fibroblasts
To determine whether iGABA neurons could be generated from
human cells, we overexpressed the five TFs into naive human
iPSCs (hiPSCs) (Figure 7A). Three weeks after transgene deliv-
ery, more than 50% of total MAP2+ cells obtained were
GABA+MAP2+; conversely, very few cells in Ascl1 only infected
hiPSC control revealed GABA+ (n = 3) (Figures 7B, 7B0, and 7D).
Interestingly, in the AFSD5L condition, 90% of reprogrammed
neurons co-expressed MAP2 and PV, while only occasionally
they resulted positive for SST (Figures 7C and 7D). To determine
the efficiency of the conversion, hiPSCs were infected with
AFSD5L together with I12bGFP reporter lentivirus. We observed
by FACS that a large fraction of AFSD5L reprogrammed cells
turned on the GFP reporter while only very few in rtTa infected
control (33.9% ± 9.2% in AFSD5L versus 4.7% ± 2.7% in rtTa
over the total cell number, n = 4). By immunofluorescence, we
could assess that most of the GFP+ cells co-expressed GABA
and, a considerable part of the GABAergic population was
labeled by the reporter (Figure S7A). Taking into account these
data and the FACS results, we could estimate that more than
30% of the total cells were GABAergic under this experimental
model (Figure S7A). To further study the nature of the reprog-
rammed neurons, we analyzed gene expression by qRT-PCR
on the FACS fraction of GFP+ iGABA neurons in comparison to
rtTa/ I12bGFP only infected hiPSCs, naive non-induced hiPSCs
(negative control), and human adult cortex (positive control) (Fig-
ures S7B–S7B0). We found that several critical genes specifying
the GABAergic nature such as GAD1, PV, SST, DLX1, and DLX2
were upregulated in human iGABA neurons (Figures S7C–S7C0).
Of note, no change in VGLUT1 expression was observed, indi-
cating that our cocktail did not generate glutamatergic neurons
(Figure S7C0).
We next tested the electrical activity of human iGABA
neurons after co-culturing them with hippocampal primary
neurons. To allow their identification, hiPSCs were infected
with our TF cocktail and I12bGFP reporter (Figure 7E). After
4 weeks, iGABA neurons expressed Na+ channels (Figures
7F and 7F0); accordingly, they exhibited voltage-gated Na+
and K+ currents that were elicited by 10-mV voltage steps in
voltage-clamp mode and fired repetitive APs in response to
suprathreshold current injection in current-clamp (31.3% of
the total patched cells, n = 67; Figures 7G and 7H). Reprog-
rammed cells expressed both pre-synaptic and post-synaptic
markers Synaptotagmin-1 and HOMER1, (Figures 7I–7J0) and
exhibited spontaneous glutamatergic and GABAergic synaptic
activity (Figure 7K), indicating their ability to form functional
synapses.CellThen, we set out to reprogram human fibroblasts using
AFSD5L TFs associated with the expression of the anti-
apoptotic protein Bcl2 to enhance cell survival (Figure 7L). After
7 DIV, approximately 25% of the total cells were GABA+ and
a large number of cells expressed TUBB3 and PV (Figures
7M–7O). No GABAergic cells were found in rtTA infected
controls (data not shown). After 35 days in co-culture with rat
primary neurons, the GFP+ reprogrammed cells exhibited
voltage-gated Na+ and K+ currents (Figures 7P and 7Q) and pro-
duced repetitive AP (33.3% of total patched cells, n = 6, Fig-
ure 7R) indicating their functional maturation. Altogether, these
results demonstrate that the AFSD5L cocktail is sufficient in
the human setting to both accelerate hiPSC differentiation into
GABAergic neurons and elicit human fibroblast direct neuronal
reprogramming.
DISCUSSION
Following a comparative screening with 22 candidate TFs, we
report a minimal number of TFs sufficient to obtain telencephalic
GABAergic IN-like cells by direct reprogramming of mouse and
human fibroblasts. The final composition of the cocktail is sur-
prising for some reasons. Ascl1, Dlx5, and Lhx6 are considered
obvious inducers of GABAergic interneuron fate (Casarosa
et al., 1999; Fode et al., 2000; Liodis et al., 2007; Poitras et al.,
2007; Wang et al., 2010). Differently, Sox2 and Foxg1 were not
expected to play such a significant role in this process. They
are both expressed during early forebrain development and
contribute to early events of ventral forebrain identity specifica-
tion by activating Nkx2.1 expression (Manuel et al., 2010; Ferri
et al., 2013). We do not favor the idea that this mechanism is
acting during fibroblast reprogramming, because Nkx2.1 is
induced only in a marginal fraction of iGABA-INs during their
conversion. Alternatively, we propose that Ascl1, Sox2, and
Foxg1 have amore direct cooperation in activating themolecular
machinery responsible for GABAergic specification. In support
of this hypothesis, silencing of either Foxg1 or Sox2 is sufficient
to block in a cell-autonomous manner the ability of Ascl1 to
induce a GABAergic neuronal fate when overexpressed in
cortical progenitor cells.
Furthermore, we showed that SOX2 and ASCL1 cooperate in
the same protein complex to bind Dlx1/2 enhancer. Our data
suggest that the binding is favored only when also FOXG1 is pre-
sent, although it itself was never detected on the I12b enhancer.
One explanation for this finding is that FOXG1, similarly to other
forkhead-box proteins, may act as a chromatin pioneer factor
(Watts et al., 2011; Iwafuchi-Doi and Zaret, 2014) and open the
repressed chromatin to enable SOX2 and ASCL1 binding to
the locus triggering I12b enhancer expression. Our screening
identified a transcriptional network that enables cells to acquire
GABAergic fate not only in fibroblasts but also in forebrain devel-
opment. However, at least in vivo, the described mechanism is
probably enriched by other partners and expression dynamics,
because Ascl1 is normally expressed at low levels in cortical pro-
genitors as well (Fode et al., 2000). These findings helps in clar-
ifying a conundrum lasting since the initial discovery of iN cells;
that is, why Ascl1 alone reprograms fibroblasts into glutamater-
gic iN cells, even if it is a key factor for the GABAergic neuronal
identity during CNS development.Stem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Inc. 727
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In the direct reprogramming scenario, we established a proto-
col in which the various TFs of the cocktail were subject to
differential temporal regulation. In fact, Sox2 and Foxg1 are tran-
siently expressed only in the first 12–14 DIV days of the reprog-
ramming and then can be downregulated to allow the correct
maturation of iGABA-INs. This dual regulation system recapitu-
lates to great extent the expression profile of these two TFs
during the origin of cortical INs in vivo, as both of them are
highly expressed in ventral telencephalic VZ and then Sox2 is
silenced while Foxg1 expression is downregulated in postmi-
totic GABAergic neurons.
Remarkably, in addition to developing a specific neuronal sub-
type, iGABA-INs are endowed with a defined regional identity.
Molecular profiling showed pronounced activation of forebrain-
restricted markers, while other markers associated with different
brain regions or spinal cord, were undetectable. Of note, most of
the obtained GAD67-GFP+ cells expressed PV already 21 days
after infection while developing cortical INs do not activate PV
expression before 3 weeks of postnatal development. This im-
plies that the forced expression of the transgenes at supra-phys-
iological levels is able to accelerate the onset of PV expression or
that a subset of TFs directly activate its own promoter. Decipher-
ing the transcriptional hierarchy that links these TFs to the activa-
tion of the PV gene would be an extremely interesting topic for
future research.
iGABA-INs differentiated in co-culture with primary neurons
for 4 weeks exhibited a fast repetitive firing with some neurons
achieving frequencies over 70 Hz and a relatively large AHP.
However, we could not record the frank fast-spiking activity
typical of PV INs. This is unexpected finding considering that
both Kcnc1 and Kcnc2 genes, codifying for potassium voltage-
gated channel Kv3.1 and Kv3.2 responsible for the fast-spiking
activity of the PV+ INs were also expressed in iGABA-INs. We
can speculate that more time is required for their completematu-
ration in vitro or that some other unknown molecular component
necessary for fast spiking activity is missing.Figure 5. iGABA-INs Functionally Integrate into Neuronal Networks an
(A) Representative TEM micrographs of a GFP+ iGABA-IN (green) labeled with a
(B) TEM image of a GFP+ postsynaptic neuron connected to a presynaptic neur
(C) TEM image of a GFP+ presynaptic terminal coupled with a postsynaptic n
highlighted in green. Scale bars represent 2 mm (A) and 200 nm (B and C).
(D–E0) Stainings for GABAA receptor (D) and HOMER1 (E) and relative magnificat
(F) Representative traces of sEPSCs and sIPSCs recorded in iGABA-INs after 3
(G) Occurrence of sEPSCs and sIPSCs (n > 10 per time point) recorded at 1, 2, and
of iGABA-INs analyzed.
(H–I0) Staining for GABA and VGAT on iGABA-INs at 3 weeks in co-culture and r
(J) Concentration of GABA released in culture medium by cortical primary neuro
measured by ELISA.
(K) Scheme of iGABA-INs infected with a ChR2 expressing lentivirus the day bef
inhibitory function 3 weeks later.
(L) Representative voltage-clamp recording showing that a long-lasting (500 ms
expressing iGABA-INs at 3 weeks in co-culture. In lower image, a representative
AP in the same cells.
(M) Fluorescence/phase-contrast merged microphotographs with a patch pipette
ChR2+ iGABA-INs whereas the phase-contrast image identifies the patched neu
(N) Representative current traces showing ChR2 activation by a 10 ms light puls
eIPSCs also develop in the absence of Dlx5 and are fully blocked by the GA
depression at short interpulse intervals (100 ms) and full recovery at longer time
(n = 7). **p < 0.01 t Student’s unpaired two-tailed t test.
In (B)–(D), Hoechst was used to stain nuclei.
CellFurthermore, we have evaluated the effectiveness of this
strategy for the generation of GABAergic neurons from human
cells. Using a single-step differentiation approach (Theka et al.,
2013; Zhang et al., 2013), we have demonstrated that the
five TFs were sufficient to differentiate hiPSCs directly into
iGABA neurons. In such way, GABAergic neuronal fate has
been induced in only 3 weeks after the infection and reprog-
rammed neurons acquired functionality after 1 month upon
co-culture with primary neurons. This strategy strongly accel-
erates hiPSC differentiation into forebrain GABAergic neurons
with respect to other reported protocols that rely on progenitor
intermediates and sequential stimulations with morphogens
(Nicholas et al., 2013; Maroof et al., 2013). Moreover, we
could convert human fibroblasts into GABAergic neurons
with the same cocktail enriched with the anti-apoptotic protein
Bcl2, allowing us to overcome cell mortality after viral infection,
one of the main hurdles in direct reprogramming of human
cells.
In this study, graftings in adult mouse brain were performed
to assess the integration and functional competence of
iNeurons. After transplantation, iGABA-INs survived at least
8 weeks in the adult mouse hippocampus and some of them
were able to migrate out of the transplanted area toward the
CA1 or DG in the hippocampus, although many remained
localized close to the injection site. Analysis of iGABA-IN
gene expression profile at 12-14 DIV, when all the factors
are induced, revealed that Doublecortin (Dcx), a marker of
migrating neuroblasts (Gleeson et al., 1999) is activated. The
migration ability of iGABA-INs might be then improved by ex-
tending dox administration in transplanted animals to keep
high the levels of Foxg1 and Sox2. Silencing of Ascl1 should
also be exploited to further improve their maturation. However,
the adult brain parenchyma might represent a particular hostile
environment for directly reprogrammed neurons to further
differentiate and mature. This might explain why iGABA-INs
lose PV expression after grafting; alternatively, PV loss ofd Inhibit the Activity of Other Neurons
nti-GFP antibody and immunogold.
on of the feeder layer.
euron of the feeder layer. The GFP signal (black gold-enhanced particles) is
ions (D0–E0 ).
weeks in co-culture.
3 weeks and 3 weeks without Dlx5 is shown in percentage of the total number
elative magnification.
ns, control MEFs, iGABA-INs, and iGABA-INs without Dlx5 (not in co-culture)
ore (13 DIV) being sorted and replated on primary neurons and tested for their
, upper imagel) light stimulus (480 nm) activates an inward current in ChR2-
current clamp recording shows that a short-lasting (10 ms) light pulse elicits an
sealed on a GFP-negative feeder neuron. The fluorescent image shows GFP-
ron in the same optical field.
e: triggering APs in iGABA-INs evokes eIPSCs in the patched feeder neuron.
BAA antagonist bicuculline (30 mM). iGABA-INs exhibit marked paired-pulse
intervals (1 s), a typical feature of inhibitory transmission in cultured neurons
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Figure 6. Functional Integration of iGABA-
INs in Mouse Hippocampus
(A) Scheme showing iGABA-INs sorted and
transduced with ChR2 before being transplanted
in adult mouse hippocampi.
(B) GFP+ grafted iGABA-INs in the hippocampus
6 weeks after transplantation.
(C and D) Representative images of iGABA-INs
grafted in the DG showing a mature morphology.
(E–E0) Staining for GFP and GABA.
(F–I) Representative images of iGABA-INs
migrated out of the injection area.
(J–J0) Example of a patched iGABA-IN in acute
slice visualized in bright field and displaying GFP
fluorescence upon illumination with blue light; the
position of the patch pipette is emphasized by the
drawn lines.
(K) Left: AP firing of a transplanted iGABA-INs in
response to injection of a suprathreshold current
pulse (40 pA, 500ms). Right: voltage-clamp traces
showing inward Na+ and outward K+ currents in
response to a series of 10-mV voltage steps from a
resting Vm of 70 mV.
(L) Representative traces showing sEPSCs from
iGABA-INs recorded in voltage-clamp configura-
tion in acute hippocampal slices before and
after extracellular perfusion with the AMPA-
and NMDA-receptor blockers CNQX (10 mM) and
D-APV (50 mM), respectively. Middle and right
images display a representative trace of an aver-
aged EPSC and the peak amplitude distribution
(five neurons/fivemice), respectively.
(M) Representative traces showing sIPSCs from
iGABA-INs recorded in voltage-clamp configura-
tion in acute hippocampal slices before and after
extracellular perfusion with the bicuculline (30 mM).
Middle and right panels display an averaged IPSC
and the peak amplitude distribution (seven neu-
rons/five mice), respectively.
(N) Representative trace showing the inhibition of
excitatory synaptic activity of a DG neuron after
optogenetic activation of neighboring iGABA-INs
expressing ChR2.
(O) Histograms reporting the amplitude and
frequency of sEPSCs recorded in a granule cell
before (pre), during (light), and after (post) the
optogenetic stimulation of iGABA neurons (three
neurons/two mice; *p < 0.05, one-way Anova with
Newman-Keuls post hoc test).
(P) Trains of GABAergic IPSPs in response to a
blue light flash (200 ms) delivered 300 mm. Light-
induced IPSPs were blocked after extracellular
perfusion with 10 mM bicuculline (gray traces)
(three neurons/five mice).
(Q) Unitary IPSCs recorded in response to blue
light stimulation at three different voltage com-
mands. IPSCs reverted at 60 mV, close to the
calculated reversal potential for Cl ions (59 mV)
in our experimental conditions.
See also Figure S6.expression might reflect some unclear intrinsic properties in
reprogrammed cells. Despite this, we showed that iGABA-
INs exhibited functional integration since they were able to
receive inputs from host neurons already at 6–8 weeks after730 Cell Stem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Ingrafting. Most importantly, their direct optogenetic stimulation
was sufficient to trigger a significant inhibitory drive on the sur-
rounding hippocampal granule cells by increasing bicuculline-
sensitive IPSPs. These data demonstrate that iGABA-INsc.
(legend on next page)
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develop into neurons with a stable inhibitory action mediated
by GABA release, which can regulate the activity of associated
neuronal circuits.
These properties of iGABA-INs promote them as promising
candidates for transplantation strategy aimed at restoring the
proper balance between inhibition and excitation in altered
neuronal circuitry associated with epilepsy and possibly other
neurological disorders.
EXPERIMENTAL PROCEDURES
Cell Cultures and Differentiation
Murine embryonic and adult fibroblasts and human lung fibroblasts MRC-5
(ATCC) were grown in MEF medium seeded, infected, and 20 hr later fresh
medium containing dox (2 mg/ml; Sigma) was added. After 48 hr, they were
shifted in neuronal-inducing medium (Caiazzo et al., 2011).
Two hiPSC lines were used, one generated from cord blood stem cells
(kindly provided by A. Giorgetti) and the other generated from skin fibroblasts
(kindly provided by C. Sala) and maintained as feeder-free cells in mTeSR1
(Stem Cell Technologies). See also Supplemental Experimental Procedures.
Molecular Cloning
cDNAs encoding TFs were cloned into Tet-o-FUW lentiviral vectors (Table S1
and Supplemental Experimental Procedures).
Immunohistochemistry
Before the infection, 8 3 104 MEFs, 4 3 105 hiPSCs, 5 3 104 MRC5/well in
24-well plates were seeded on Matrigel-coated glass coverslips and fixed in
4% paraformaldehyde. Immunofluorescences were performed as previously
described (Caiazzo et al., 2011) with antibodies listed in Table S3.
Quantifications and Statistical Analysis
GFP+, TUBB3+, and other GABAergic marker positive cells were quantified at
14 or 21 DIV by counting ten fields from at least three separate infections and
normalized to the number of cells plated or on the total of GAD67-GFP+ cells.
At least 500 cells were counted.
Data were analyzed using the two-tailed Student’s t test or by 1- or 2-way
ANOVA followed by the post hoc Bonferroni’s test in Graph Pad. Statistical
significance was set at p < 0.05. See also Supplemental Experimental
Procedures.Figure 7. Morphological and Functional Analysis of Human iGABA Neu
(A) Reprogramming strategy of hiPSCs based on the forced expression of Ascl1
(B–C0) Staining of human iGABA cells for GABA, MAP2, and PV at 21 DIV.
(D) Quantifications of GABA+MAP2+ and PV+MAP2+ cells over the total MAP2+ c
presented as means ± SEM(n = 2–5).
(E–E0 ) Staining for GABA and GFP of iGABA-neurons in co-culture.
(F–F0) Representative image of an iGABA neuron expressing Na+ channels (Nav)
(G) Top: fluorescence/phase-contrast merged microphotograph showing a patch
currents, respectively, elicited by 10-mV voltage steps in voltage-clamp mode.
(H) Examples of patch-clamp recordings of iGABA neurons after 34 days in co-c
step (50 pA).
(I–J0) GFP+ iGABA cells developing Synaptotagmin-1 (Syt1)+ and HOMER1 (Hom
(K) Voltage-clamp recordings of spontaneous synaptic currents. Top and middle
IPSCs (recorded at 20 mV), respectively. Insets on the right display a mean uni
after perfusion with NBQX and gabazine (GBZ), no synaptic currents were detecte
here).
(L) Reprogramming strategy to directly convert human fibroblasts into iGABA ne
(M–N0 0) Staining of iGABA cells at 7 DIV for GABA, PV, and TUBB3.
(O) Quantifications of GABA+TUBB3+ and PV+TUBB3+ cells over TUBB3+ cell
(n = 2).
(P–P0) Morphology of GABA+GFP+ iGABA neurons in co-culture at 35 DIV.
(Q) Inward and outward Na+ and K+ currents elicited by 10-mV voltage steps in v
(R) Example of iGABA neuron repetitive AP firing in response to injection of a sup
In (B)–(E), (M)–(N0 0), and (P)–(P0), hoechst was used to stain nuclei. Scale bar repr
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ChIP experiments were performed as in Castro et al. (2006). Chromatin was
obtained from E14.5 ventral forebrain and IP with anti-ASCL1 (1 mg/500 ml,
mouse, BD PharMingen), anti-SOX2 (1 mg/500 ml mouse, R&D Systems), anti-
FOXG1 (1mg/500 ml, rabbit, Abcam), and anti-GFP (1 mg/500 ml, mouse and rab-
bit, Molecular Probes). See also Supplemental Experimental Procedures.
Protein Co-immunoprecipitations
coIPs were performed on HEK293T and E14.5 ventral forebrain nuclear ex-
tracts. See also Supplemental Experimental Procedures.
Electrophysiological Recordings in Hippocampal Co-cultures
iGABA-INs excitability and synaptic transmission were studied by whole-cell
current-clamp/voltage-clamp recordings between 7 and 28 DIV in co-culture.
See also Supplemental Experimental Procedures.
Electrophysiology on Brain Slices
At 4–6 weeks after iGaba-INs transplantation, mice were anesthetized and
decapitated, and 300-mm thick brain coronal slices were obtained and
whole-cell patch-clamp recordings performed. See also Supplemental Exper-
imental Procedures.
Transplantation Surgery and Stereological Analysis
iGABA-INs at 12–14 DIV were trypsinized, sorted for GFP, and resuspended at
2 3 105cells ml1 in Krebs buffer and stereotactically transplanted in P30
mouse hippocampi. Mice were maintained at San Raffaele Scientific Institute
Institutional mouse facility. All experiments were conducted in accordance
with the guidelines established by the European Communities Council (Direc-
tive 2010/63/EU of 22 September 2010) and were approved by the local Insti-
tutional Animal Care and Use Committees and the Italian Ministry of Health.
See also Supplemental Experimental Procedures.
ACCESSION NUMBERS
The accession number for the RNA seq data reported in this paper is GEO:
GSE74065.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2015.09.002.rons Derived by Direct Reprogramming of hiPSCs and Fibroblasts
, Foxg1, Sox2, Dlx5, and Lhx6.
ells and quantification of SST+GABA+ cells over the total GABA+ cells. Data are
, GFP, and GABA.
pipette sealed on a GFP+ iGABA cell. Bottom: inward and outward Na+ and K+
ulture. Repetitive AP firing in response to injection of a suprathreshold current
)+ pre- and post-synaptic terminals, respectively.
traces show inward-going EPSCs (recorded at 70 mV) and outward-going
tary EPSC (top) and IPSC (bottom; both averages of 15 events). Bottom trace:
d at any command potential (a portion of a trace recorded at70 mV is shown
urons adding Bcl2 to our combination.
population with neuronal morphology. Data are presented as means ± SEM
oltage-clamp mode.
rathreshold current step (50 pA).
esents 25 mm. See also Figure S7.
c.
AUTHOR CONTRIBUTIONS
G.C. and V.B. conceived and planned the experiments; G.C. performed the ex-
periments and analyzed data; G.L., L.M., S.S, L.Y., and S.T. performed elec-
trophysiological recordings; A.R. performed experiments on human cells;
A.S. carried out IUEs; M.C. and S.G. contributed to lentivirus cloning; L.M. per-
formed ChIP assays; M.T.D’A. helped in stereotactic transplantations; E.C.
performed coIPs; D.A. and A.D. performed and analyzed RNA-seq experi-
ments; D.L. performed GABA-ELISA; M.O. performed EM imaging; and
G.C., R.R.G., F.B., S.T., and V.B. supervised the project and wrote the paper.
ACKNOWLEDGMENTS
We thank A. Buffo, A. Dityatev, B. Berninger, V. Pachnis, B. Rudy, and T. Ka-
neko for helpful discussions and sharing of mice and reagents. We are grateful
to the FRACTAL core facility for flow cytometry and to M. Andreazzoli for crit-
ical reading of the manuscript. This work was supported by the European
Research Council (AdERC #340527) and IIT-SEED project (to V.B.) and EC
FP7-Health-2013-Innovation integrating project ‘‘DESIRE’’ (to F.B. and V.B.).
G.C. is supported by a fellowship from Fondazione Veronesi. D.A. is supported
by the Collaborative Research Center 655 from the Deutsche Forschungsge-
meinschaft, andR.R.G. is supported by the Russian Science Foundation (grant
# 4-50-00069).
Received: September 12, 2014
Revised: June 21, 2015
Accepted: September 2, 2015
Published: October 29, 2015
REFERENCES
Alvarez-Dolado, M., Calcagnotto, M.E., Karkar, K.M., Southwell, D.G., Jones-
Davis, D.M., Estrada, R.C., Rubenstein, J.L., Alvarez-Buylla, A., and Baraban,
S.C. (2006). Cortical inhibition modified by embryonic neural precursors
grafted into the postnatal brain. J. Neurosci. 26, 7380–7389.
Anderson, S.A., Marı´n, O., Horn, C., Jennings, K., and Rubenstein, J.L. (2001).
Distinct cortical migrations from the medial and lateral ganglionic eminences.
Development 128, 353–363.
Baraban, S.C., Southwell, D.G., Estrada, R.C., Jones, D.L., Sebe, J.Y., Alfaro-
Cervello, C., Garcı´a-Verdugo, J.M., Rubenstein, J.L., and Alvarez-Buylla, A.
(2009). Reduction of seizures by transplantation of cortical GABAergic inter-
neuron precursors into Kv1.1 mutant mice. Proc. Natl. Acad. Sci. USA 106,
15472–15477.
Bra´z, J.M., Sharif-Naeini, R., Vogt, D., Kriegstein, A., Alvarez-Buylla, A.,
Rubenstein, J.L., and Basbaum, A.I. (2012). Forebrain GABAergic neuron pre-
cursors integrate into adult spinal cord and reduce injury-induced neuropathic
pain. Neuron 74, 663–675.
Caiazzo, M., Dell’Anno, M.T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo,
D., Sotnikova, T.D., Menegon, A., Roncaglia, P., Colciago, G., et al. (2011).
Direct generation of functional dopaminergic neurons from mouse and human
fibroblasts. Nature 476, 224–227.
Calcagnotto, M.E., Ruiz, L.P., Blanco, M.M., Santos-Junior, J.G., Valente,
M.F., Patti, C., Frussa-Filho, R., Santiago, M.F., Zipancic, I., Alvarez-Dolado,
M., et al. (2010). Effect of neuronal precursor cells derived from medial gangli-
onic eminence in an acute epileptic seizure model. Epilepsia 51 (Suppl 3 ),
71–75.
Casarosa, S., Fode, C., and Guillemot, F. (1999). Mash1 regulates neurogen-
esis in the ventral telencephalon. Development 126, 525–534.
Castro, D.S., Skowronska-Krawczyk, D., Armant, O., Donaldson, I.J., Parras,
C., Hunt, C., Critchley, J.A., Nguyen, L., Gossler, A., Go¨ttgens, B., et al. (2006).
Proneural bHLH and Brn proteins coregulate a neurogenic program through
cooperative binding to a conserved DNA motif. Dev. Cell 11, 831–844.
Colasante, G., Sessa, A., Crispi, S., Calogero, R., Mansouri, A., Collombat, P.,
and Broccoli, V. (2009). Arx acts as a regional key selector gene in the ventral
telencephalon mainly through its transcriptional repression activity. Dev. Biol.
334, 59–71.CellDanjo, T., Eiraku, M., Muguruma, K., Watanabe, K., Kawada, M., Yanagawa,
Y., Rubenstein, J.L., and Sasai, Y. (2011). Subregional specification of embry-
onic stem cell-derived ventral telencephalic tissues by timed and combinatory
treatment with extrinsic signals. J. Neurosci. 31, 1919–1933.
Du, J., Zhang, L., Weiser, M., Rudy, B., and McBain, C.J. (1996).
Developmental expression and functional characterization of the potassium-
channel subunit Kv3.1b in parvalbumin-containing interneurons of the rat hip-
pocampus. J. Neurosci. 16, 506–518.
Erisir, A., Lau, D., Rudy, B., and Leonard, C.S. (1999). Function of specific K(+)
channels in sustained high-frequency firing of fast-spiking neocortical inter-
neurons. J. Neurophysiol. 82, 2476–2489.
Ferri, A., Favaro, R., Beccari, L., Bertolini, J., Mercurio, S., Nieto-Lopez, F.,
Verzeroli, C., La Regina, F., De Pietri Tonelli, D., Ottolenghi, S., et al. (2013).
Sox2 is required for embryonic development of the ventral telencephalon
through the activation of the ventral determinants Nkx2.1 and Shh.
Development 140, 1250–1261.
Fode, C., Ma, Q., Casarosa, S., Ang, S.L., Anderson, D.J., and Guillemot, F.
(2000). A role for neural determination genes in specifying the dorsoventral
identity of telencephalic neurons. Genes Dev. 14, 67–80.
Gilani, A.I., Chohan, M.O., Inan, M., Schobel, S.A., Chaudhury, N.H.,
Paskewitz, S., Chuhma, N., Glickstein, S., Merker, R.J., Xu, Q., et al. (2014).
Interneuron precursor transplants in adult hippocampus reverse psychosis-
relevant features in a mouse model of hippocampal disinhibition. Proc. Natl.
Acad. Sci. USA 111, 7450–7455.
Gleeson, J.G., Lin, P.T., Flanagan, L.A., and Walsh, C.A. (1999). Doublecortin
is a microtubule-associated protein and is expressed widely by migrating
neurons. Neuron 23, 257–271.
Hunt, R.F., Girskis, K.M., Rubenstein, J.L., Alvarez-Buylla, A., and Baraban,
S.C. (2013). GABA progenitors grafted into the adult epileptic brain control
seizures and abnormal behavior. Nat. Neurosci. 16, 692–697.
Iwafuchi-Doi, M., and Zaret, K.S. (2014). Pioneer transcription factors in cell re-
programming. Genes Dev. 28, 2679–2692.
Kitamura, K., Yanazawa,M., Sugiyama, N., Miura, H., Iizuka-Kogo, A., Kusaka,
M., Omichi, K., Suzuki, R., Kato-Fukui, Y., Kamiirisa, K., et al. (2002). Mutation
of ARX causes abnormal development of forebrain and testes in mice and
X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 32,
359–369.
Liodis, P., Denaxa, M., Grigoriou, M., Akufo-Addo, C., Yanagawa, Y., and
Pachnis, V. (2007). Lhx6 activity is required for the normal migration and spec-
ification of cortical interneuron subtypes. J. Neurosci. 27, 3078–3089.
Liu,M.L., Zang, T., Zou, Y., Chang, J.C., Gibson, J.R., Huber, K.M., and Zhang,
C.L. (2013). Small molecules enable neurogenin 2 to efficiently convert human
fibroblasts into cholinergic neurons. Nat. Commun. 4, 2183.
Manuel, M., Martynoga, B., Yu, T., West, J.D., Mason, J.O., and Price, D.J.
(2010). The transcription factor Foxg1 regulates the competence of telence-
phalic cells to adopt subpallial fates in mice. Development 137, 487–497.
Marı´n, O., and Rubenstein, J.L. (2001). A long, remarkable journey: tangential
migration in the telencephalon. Nat. Rev. Neurosci. 2, 780–790.
Maroof, A.M., Brown, K., Shi, S.H., Studer, L., and Anderson, S.A. (2010).
Prospective isolation of cortical interneuron precursors from mouse embry-
onic stem cells. J. Neurosci. 30, 4667–4675.
Maroof, A.M., Keros, S., Tyson, J.A., Ying, S.W., Ganat, Y.M., Merkle, F.T., Liu,
B., Goulburn, A., Stanley, E.G., Elefanty, A.G., et al. (2013). Directed differen-
tiation and functional maturation of cortical interneurons from human embry-
onic stem cells. Cell Stem Cell 12, 559–572.
Martı´nez-Cerden˜o, V., Noctor, S.C., Espinosa, A., Ariza, J., Parker, P., Orasji,
S., Daadi, M.M., Bankiewicz, K., Alvarez-Buylla, A., and Kriegstein, A.R.
(2010). Embryonic MGE precursor cells grafted into adult rat striatum integrate
and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell 6,
238–250.
Nicholas, C.R., Chen, J., Tang, Y., Southwell, D.G., Chalmers, N., Vogt, D.,
Arnold, C.M., Chen, Y.J., Stanley, E.G., Elefanty, A.G., et al. (2013).
Functional maturation of hPSC-derived forebrain interneurons requires anStem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier Inc. 733
extended timeline and mimics human neural development. Cell Stem Cell 12,
573–586.
Poitras, L., Ghanem, N., Hatch, G., and Ekker, M. (2007). The proneural deter-
minant MASH1 regulates forebrain Dlx1/2 expression through the I12b inter-
genic enhancer. Development 134, 1755–1765.
Son, E.Y., Ichida, J.K., Wainger, B.J., Toma, J.S., Rafuse, V.F., Woolf, C.J.,
and Eggan, K. (2011). Conversion of mouse and human fibroblasts into func-
tional spinal motor neurons. Cell Stem Cell 9, 205–218.
Southwell, D.G., Froemke, R.C., Alvarez-Buylla, A., Stryker, M.P., and Gandhi,
S.P. (2010). Cortical plasticity induced by inhibitory neuron transplantation.
Science 327, 1145–1148.
Stu¨hmer, T., Anderson, S.A., Ekker, M., and Rubenstein, J.L. (2002). Ectopic
expression of the Dlx genes induces glutamic acid decarboxylase and Dlx
expression. Development 129, 245–252.
Tamamaki, N., Yanagawa, Y., Tomioka, R., Miyazaki, J., Obata, K., and
Kaneko, T. (2003). Green fluorescent protein expression and colocalization
with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in
mouse. J. Comp. Neurol. 467, 60–79.
Theka, I., Caiazzo, M., Dvoretskova, E., Leo, D., Ungaro, F., Curreli, S.,
Manago’, F., Dell’Anno, M.T., Pezzoli, G., Gainetdinov, R.R., et al. (2013).
Rapid generation of functional dopaminergic neurons from human iPSCs
through a single –step procedure using cell lineage transcription factors.
Stem Cells Transl. Med. 2, 473–479.
Tong, L.M., Djukic, B., Arnold, C., Gillespie, A.K., Yoon, S.Y., Wang, M.M.,
Zhang, O., Knoferle, J., Rubenstein, J.L., Alvarez-Buylla, A., and Huang, Y.
(2014). Inhibitory interneuron progenitor transplantation restores normal
learning andmemory in ApoE4 knock-in micewithout or with Ab accumulation.
J. Neurosci. 34, 9506–9515.734 Cell Stem Cell 17, 719–734, December 3, 2015 ª2015 Elsevier InTyson, J.A., Goldberg, E.M., Maroof, A.M., Xu, Q., Petros, T.J., and Anderson,
S.A. (2015). Duration of culture and sonic hedgehog signaling differentially
specify PV versus SST cortical interneuron fates from embryonic stem cells.
Development 142, 1267–1278.
Victor, M.B., Richner, M., Hermanstyne, T.O., Ransdell, J.L., Sobieski, C.,
Deng, P.Y., Klyachko, V.A., Nerbonne, J.M., and Yoo, A.S. (2014).
Generation of human striatal neurons by microRNA-dependent direct conver-
sion of fibroblasts. Neuron 84, 311–323.
Vierbuchen, T., Ostermeier, A., Pang, Z.P., Kokubu, Y., Su¨dhof, T.C., and
Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by
defined factors. Nature 463, 1035–1041.
Wang, Y., Dye, C.A., Sohal, V., Long, J.E., Estrada, R.C., Roztocil, T., Lufkin,
T., Deisseroth, K., Baraban, S.C., and Rubenstein, J.L. (2010). Dlx5 and Dlx6
regulate the development of parvalbumin-expressing cortical interneurons.
J. Neurosci. 30, 5334–5345.
Watts, J.A., Zhang, C., Klein-Szanto, A.J., Kormish, J.D., Fu, J., Zhang, M.Q.,
and Zaret, K.S. (2011). Study of FoxA pioneer factor at silent genes reveals
Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal
adenocarcinoma development. PLoS Genet. 7, e1002277.
Yun, K., Fischman, S., Johnson, J., Hrabe de Angelis, M., Weinmaster, G., and
Rubenstein, J.L. (2002). Modulation of the notch signaling by Mash1 and Dlx1/
2 regulates sequential specification and differentiation of progenitor cell types
in the subcortical telencephalon. Development 129, 5029–5040.
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S.,
Patzke, C., Acuna, C., Covy, J., et al. (2013). Rapid single-step induction of
functional neurons from human pluripotent stem cells. Neuron 78, 785–798.c.
